Cited by 317Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular HealthLipid metabolism and disorders

The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.

Genetic Variant of the Scavenger Receptor BI in Humans

Open access

Vergeer, Menno, Korporaal, Suzanne J.A., Franssen, Remco, Meurs, Illiana, Out, Ruud, Hovingh, G. Kees, Hoekstra, Menno, Sierts, Jeroen A., Dallinga-Thie, Geesje M., Motazacker, Mohammad Mahdi, Holleboom, Adriaan G., Van Berkel, Theo J.C., Kastelein, John J.P., Van Eck, Miranda, Kuivenhoven, Jan Albert·2011·New England Journal of Medicine

DOI 10.1056/nejmoa0907687

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: In mice, the scavenger receptor class B type I (SR-BI) is essential for the delivery of high-density lipoprotein (HDL) cholesterol to the liver and steroidogenic organs. Paradoxically, elevated HDL cholesterol levels are associated with increased atherosclerosis in SR-BI-knockout mice. It is unclear what role SR-BI plays in human metabolism. METHODS: We sequenced the gene encoding SR-BI in persons with elevated HDL cholesterol levels and identified a family with a new missense mutation (P297S). The functional effects of the P297S mutation on HDL binding, cellular cholesterol uptake and efflux, atherosclerosis, platelet function, and adrenal function were studied. RESULTS: Cholesterol uptake from HDL by primary murine hepatocytes that expressed mutant SR-BI was reduced to half of that of hepatocytes expressing wild-type SR-BI. Carriers of the P297S mutation had increased HDL cholesterol levels (70.4 mg per deciliter [1.8 mmol per liter], vs. 53.4 mg per deciliter [1.4 mmol per liter] in noncarriers; P<0.001) and a reduced capacity for efflux of cholesterol from macrophages, but the carotid artery intima-media thickness was similar in carriers and in family noncarriers. Platelets from carriers had increased unesterified cholesterol content and impaired function. In carriers, adrenal steroidogenesis was attenuated, as evidenced by decreased urinary excretion of sterol metabolites, a decreased response to corticotropin stimulation, and symptoms of diminished adrenal function. CONCLUSIONS: We identified a family with a functional mutation in SR-BI. The mutation carriers had increased HDL cholesterol levels and a reduction in cholesterol efflux from macrophages but no significant increase in atherosclerosis. Reduced SR-BI function was associated with altered platelet function and decreased adrenal steroidogenesis. (Funded by the European Community and others.).

Integrity signals

Registry

Crossref · 10.1056/nejmoa0907687

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A simplified system for generating recombinant adenoviruses
He, T., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W., & Vogelstein, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2509 · Cited by 3,209
Effects of torcetrapib in patients at high risk for coronary events
Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M., Kastelein, J. J. P., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J.-C., Waters, D. D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706628 · Cited by 3,139
Self-citation
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., & Krieger, M. (1996) · Science · doi:10.1126/science.271.5248.518 · Cited by 2,026
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L.-H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O. F., et al. (1999) · Nature Genetics · doi:10.1038/11905 · Cited by 1,687
Self-citation
Prediction of deleterious human alleles
Sunyaev, S. R. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.6.591 · Cited by 1,053
Cholesteryl Ester Transfer Protein
Barter, P. J., Brewer, H. B., Chapman, M. J., Hennekens, C. H., Rader, D. J., & Tall, A. R. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000054658.91146.64 · Cited by 868
A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism
Rigotti, A., Trigatti, B. L., Penman, M., Rayburn, H., Herz, J., & Krieger, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12610 · Cited by 860
Scavenger Receptor BI Promotes High Density Lipoprotein-mediated Cellular Cholesterol Efflux
Ji, Y. I., Jian, B., Wang, N., Sun, Y., Moya, M. D. L. L., Phillips, M. C., Rothblat, G. H., Swaney, J. B., & Tall, A. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.20982 · Cited by 694
Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo
Wang, X., Collins, H. L., Ranalletta, M., Fuki, I. V., Billheimer, J. T., Rothblat, G. H., Tall, A. R., & Rader, D. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32057 · Cited by 593

Flagged first, then by citations

Show all 40 references

1 of the 40 references couldn’t be matched to a known paper.

Sorted by citations

Cholesterol Efflux and Atheroprotection: Advancing the Concept of Reverse Cholesterol Transport
Rosenson, R. S., Brewer, H. B., Davidson, W. S., Fayad, Z. A., Fuster, V., Goldstein, J., Hellerstein, M., Jiang, X.-C., Phillips, M. C., Rader, D. J., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.066589 · Cited by 953
Bile acid signaling in metabolic disease and drug therapy
Li, T., & Chiang, J. Y. L. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008201 · Cited by 935
Foam cells in atherosclerosis
Yu, X.-H., Fu, Y., Zhang, D., Yin, K., & Tang, C. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.06.006 · Cited by 772
Early steps in steroidogenesis: intracellular cholesterol trafficking
Miller, W. L., & Bose, H. S. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r016675 · Cited by 593
Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease
Zanoni, P., Khetarpal, S. A., Larach, D. B., Hancock-Cerutti, W. F., Millar, J. S., Cuchel, M., DerOhannessian, S., Kontush, A., Surendran, P., Saleheen, D., et al. (2016) · Science · doi:10.1126/science.aad3517 · Cited by 545
Self-citation
Molecular Biology of Atherosclerosis
Hopkins, P. N. (2013) · Physiological Reviews · doi:10.1152/physrev.00004.2012 · Cited by 469
SR-B1: A Unique Multifunctional Receptor for Cholesterol Influx and Efflux
Shen, W., Azhar, S., & Kraemer, F. B. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021317-121550 · Cited by 421
High-density lipoproteins: A consensus statement from the National Lipid Association
Toth, P. P., Barter, P. J., Rosenson, R. S., Boden, W. E., Chapman, M. J., Cuchel, M., D'Agostino, R. B., Davidson, M. H., Davidson, W. S., Heinecke, J. W., et al. (2013) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.08.001 · Cited by 336
HDL cholesterol: reappraisal of its clinical relevance
März, W., Kleber, M. E., Scharnagl, H., Speer, T., Zewinger, S., Ritsch, A., Parhofer, K. G., von Eckardstein, A., Landmesser, U., & Laufs, U. (2017) · Clinical Research in Cardiology · doi:10.1007/s00392-017-1106-1 · Cited by 275
Platelets in atherosclerosis
von Hundelshausen, P., & Lievens, D. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-08-0592 · Cited by 282
Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products
Wang, D., Yang, Y., Lei, Y., Tzvetkov, N. T., Liu, X., Yeung, A. W. K., Xu, S., & Atanasov, A. G. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017178 · Cited by 223
Lipoprotein receptor signalling in atherosclerosis
Mineo, C. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz338 · Cited by 232
Molecular mechanisms of vascular effects of High‐density lipoprotein: alterations in cardiovascular disease
Besler, C., Lüscher, T. F., & Landmesser, U. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200224 · Cited by 226
SR-BI: A Multifunctional Receptor in Cholesterol Homeostasis and Atherosclerosis
Linton, M. F., Tao, H., Linton, E. F., & Yancey, P. G. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.02.001 · Cited by 221
Regulation of cholesterol homeostasis
van der Wulp, M. Y. M., Verkade, H. J., & Groen, A. K. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.007 · Cited by 210
Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement
Hegele, R. A., Borén, J., Ginsberg, H. N., Arca, M., Averna, M., Binder, C. J., Calabresi, L., Chapman, M. J., Cuchel, M., von Eckardstein, A., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30264-5 · Cited by 204
Self-citation
Metabolic and functional relevance of HDL subspecies
Asztalos, B. F., Tani, M., & Schaefer, E. J. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283468061 · Cited by 201
Emerging role of high density lipoproteins as a player in the immune system
Norata, G. D., Pirillo, A., Ammirati, E., & Catapano, A. L. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.045 · Cited by 195
High-density lipoprotein as a modulator of platelet and coagulation responses
van der Stoep, M., Korporaal, S. J. A., & Eck, M. V. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu137 · Cited by 193
Self-citation
Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?
Kunnen, S., & Eck, M. V. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r024513 · Cited by 181
HDL Function and Atherosclerosis: Reactive Dicarbonyls as Promising Targets of Therapy
Linton, M. F., Yancey, P. G., Tao, H., & Davies, S. S. (2023) · Circulation Research · doi:10.1161/circresaha.123.321563 · Cited by 159
Thematic Review Series: Lipid Transfer Proteins Scavenger receptor B type 1: expression, molecular regulation, and cholesterol transport function
Shen, W.-J., Asthana, S., Kraemer, F. B., & Azhar, S. (2018) · Journal of Lipid Research · doi:10.1194/jlr.r083121 · Cited by 148
HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology
Rosenson, R. S., Brewer, H. B., Barter, P. J., Björkegren, J., Chapman, M. J., Gaudet, D., Kim, D. S., Niesor, E. J., Rye, K., Sacks, F. M., et al. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.115 · Cited by 149
The Role of Maternal-Fetal Cholesterol Transport in Early Fetal Life: Current Insights1
Baardman, M. E., Kerstjens‐Frederikse, W. S., Berger, R. M. F., Bakker, M. K., Hofstra, R. M. W., & Plösch, T. (2012) · Biology of Reproduction · doi:10.1095/biolreprod.112.102442 · Cited by 141
Mouse models of atherosclerosis and their suitability for the study of myocardial infarction
Golforoush, P. A., Yellon, D. M., & Davidson, S. M. (2020) · Basic Research in Cardiology · doi:10.1007/s00395-020-00829-5 · Cited by 135
Autoimmune Addison disease: pathophysiology and genetic complexity
Mitchell, A. L., & Pearce, S. H. S. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.245 · Cited by 120
HDL Biogenesis, Remodeling, and Catabolism
Zannis, V. I., Fotakis, P., Κούκος, Γ., Kardassis, D., Ehnholm, C., Jauhiainen, M., & Chroni, A. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-09665-0_2 · Cited by 123
High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives
Adorni, M. P., Ronda, N., Bernini, F., & Zimetti, F. (2021) · Cells · doi:10.3390/cells10030574 · Cited by 110
HDL endocytosis and resecretion
Röhrl, C., & Stangl, H. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.07.014 · Cited by 101
Understanding high-density lipoprotein function in disease: Recent advances in proteomics unravel the complexity of its composition and biology
Birner‐Gruenberger, R., Schittmayer, M., Holzer, M., & Marsche, G. (2014) · Progress in Lipid Research · doi:10.1016/j.plipres.2014.07.003 · Cited by 99
Scavenger Receptor class B type I (SR-BI): A versatile receptor with multiple functions and actions
Shen, W., Hu, J., Hu, Z., Kraemer, F. B., & Azhar, S. (2014) · Metabolism · doi:10.1016/j.metabol.2014.03.011 · Cited by 100
Intestinal CD36 and Other Key Proteins of Lipid Utilization: Role in Absorption and Gut Homeostasis
Cifarelli, V., & Abumrad, N. A. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170026 · Cited by 127
Endocytosis of lipoproteins
Zanoni, P., Velagapudi, S., Yalçınkaya, M., Rohrer, L., & von Eckardstein, A. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.06.881 · Cited by 97
Reverse Cholesterol Transport Revisited
Brufau, G., Groen, A. K., & Kuipers, F. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.181206 · Cited by 94
HDL Cholesterol Metabolism and the Risk of CHD: New Insights from Human Genetics
Vitali, C., Khetarpal, S. A., & Rader, D. J. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0940-0 · Cited by 96
HDL functionality in reverse cholesterol transport — Challenges in translating data emerging from mouse models to human disease
Lee‐Rueckert, M., Escolá‐Gil, J. C., & Kovanen, P. T. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.03.004 · Cited by 93
The Postbinding Activity of Scavenger Receptor Class B Type I Mediates Initiation of Hepatitis C Virus Infection and Viral Dissemination
Zahid, M., Turek, M., Xiao, F., Thi, V. L. D., Guérin, M., Fofana, I., Bachellier, P., Thompson, J., Delang, L., Neyts, J. H., et al. (2012) · Hepatology · doi:10.1002/hep.26097 · Cited by 89
Atheroprotective Reverse Cholesterol Transport Pathway Is Defective in Familial Hypercholesterolemia
Bellanger, N., Orsoni, A., Julia, Z., Fournier, N., Frisdal, É., Duchêne, E., Bruckert, É., Carrié, A., Bonnefont‐Rousselot, D., Pirault, J., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.227181 · Cited by 85
The HDL receptor SR-BI is associated with human prostate cancer progression and plays a possible role in establishing androgen independence
Schörghofer, D., Kinslechner, K., Preitschopf, A., Schütz, B., Röhrl, C., Hengstschläger, M., Stangl, H., & Mikula, M. (2015) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-015-0087-z · Cited by 81
Hunting human disease genes: lessons from the past, challenges for the future
Brunham, L. R., & Hayden, M. R. (2013) · Human Genetics · doi:10.1007/s00439-013-1286-3 · Cited by 84
Proteomic Plasma Membrane Profiling Reveals an Essential Role for gp96 in the Cell Surface Expression of LDLR Family Members, Including the LDL Receptor and LRP6
Weekes, M. P., Antrobus, R., Talbot, S., Hör, S., Simecek, N., Smith, D. L., Bloor, S., Randow, F., & Lehner, P. J. (2012) · Journal of Proteome Research · doi:10.1021/pr201135e · Cited by 82
HDL, Atherosclerosis, and Emerging Therapies
Hafiane, A., & Genest, J. J. (2013) · Cholesterol · doi:10.1155/2013/891403 · Cited by 82
Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis
Habets, K. L. L., Trouw, L. A., Levarht, E. W. N., Korporaal, S. J. A., Habets, P. A. M., de Groot, P. G., Huizinga, T. W. J., & Toes, R. E. M. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0665-7 · Cited by 79
Self-citation
High-Density Lipoproteins and the Immune System
Kaji, H. (2013) · Journal of Lipids · doi:10.1155/2013/684903 · Cited by 81
A New Frontier in Immunometabolism. Cholesterol in Lung Health and Disease
Fessler, M. B. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201702-136aw · Cited by 81
Association of Serum Cholesterol Efflux Capacity With Mortality in Patients With ST-Segment Elevation Myocardial Infarction
Guérin, M., Silvain, J., Gall, J., Darabi, M., Berthet, M., Frisdal, É., Hauguel‐Moreau, M., Zeitouni, M., Kernéis, M., Lattuca, B., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.080 · Cited by 81
Novel mutations in scavenger receptor BI associated with high HDL cholesterol in humans
Brunham, L., Tietjen, I., Bochem, A. E., Singaraja, R. R., Franchini, P. L., Radomski, C., Mattice, M., Legendre, A., Hovingh, G. K., Kastelein, J. J. P., et al. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01682.x · Cited by 76
Self-citation
Deficiency of Scavenger Receptor BI Leads to Impaired Lymphocyte Homeostasis and Autoimmune Disorders in Mice
Feng, H., Guo, L., Wang, D., Gao, H., Hou, G., Zheng, Z., Ai, J., Foreman, O., Daugherty, A., & Li, X. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.234716 · Cited by 76
Macrophage SR-BI modulates autophagy via VPS34 complex and PPARα transcription of Tfeb in atherosclerosis
Tao, H., Yancey, P. G., Blakemore, J. L., Zhang, Y., Ding, L., Jerome, W. G., Brown, J. D., Vickers, K. C., & Linton, M. F. (2021) · Journal of Clinical Investigation · doi:10.1172/jci94229 · Cited by 78
Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in Humans
Mendivil, C. O., Furtado, J. D., Morton, A. M., Wang, L., & Sacks, F. M. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306138 · Cited by 76
Rare SCARB1 mutations associate with high-density lipoprotein cholesterol but not with coronary artery disease
Helgadóttir, A., Sulem, P., Þorgeirsson, G., Grétarsdóttir, S., Þorleifsson, G., Jensson, B. Ö., Arnadottir, G. A., Ólafsson, Í., Eyjolfsson, G. I., Sigurðardóttir, Ó., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy169 · Cited by 74
Functions of scavenger receptor class B, type I in atherosclerosis
Mineo, C., & Shaul, P. W. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328357ba61 · Cited by 72
Lipidomic Profiling of Liver Tissue from Obesity-Prone and Obesity-Resistant Mice Fed a High Fat Diet
Nam, M., Choi, M., Jung, S., Jung, Y., Choi, J., Ryu, D. H., & Hwang, G. (2015) · Scientific Reports · doi:10.1038/srep16984 · Cited by 68
Platelet Function in Health and Disease: from Molecular Mechanisms, Redox Considerations to Novel Therapeutic Opportunities
Ferroni, P., Vazzana, N., Riondino, S., Cuccurullo, C., Guadagni, F., & Davı̀, G. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4324 · Cited by 68
Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionality
Barylski, M., Toth, P. P., Nikolic, D., Banach, M., Rizzo, M., & Montalto, G. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.11.001 · Cited by 67
Mechanisms regulating hepatic SR-BI expression and their impact on HDL metabolism
Leiva, A., Verdejo, H., Benítez, M. L., Martínez, A., Busso, D., & Rigotti, A. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.05.036 · Cited by 67
SR-BI as target in atherosclerosis and cardiovascular disease - A comprehensive appraisal of the cellular functions of SR-BI in physiology and disease
Hoekstra, M. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.01.034 · Cited by 65
Self-citation
HDL cholesterol concentrations and risk of atherosclerotic cardiovascular disease – Insights from randomized clinical trials and human genetics
Kjeldsen, E. W., Thomassen, J. Q., & Frikke‐Schmidt, R. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159063 · Cited by 70
Glycine Dimerization Motif in the N-terminal Transmembrane Domain of the High Density Lipoprotein Receptor SR-BI Required for Normal Receptor Oligomerization and Lipid Transport
Gaidukov, L., Nager, A. R., Xu, S., Penman, M., & Krieger, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.229872 · Cited by 63
Regulation of High-Density Lipoprotein on Hematopoietic Stem/Progenitor Cells in Atherosclerosis Requires Scavenger Receptor Type BI Expression
Gao, M., Zhao, D., Schouteden, S., Sorci‐Thomas, M. G., Veldhoven, P. P. V., Eggermont, K., Liu, C., Verfaillie, C. M., & Feng, Y. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304006 · Cited by 67
Evidence of a Polygenic Origin of Extreme High-Density Lipoprotein Cholesterol Levels
Motazacker, M. M., Peter, J., Treskes, M., Shoulders, C. C., Kuivenhoven, J. A., & Hovingh, G. K. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301505 · Cited by 62
Self-citation
Multiple Sclerosis is Not a Disease of the Immune System
Corthals, A. (2011) · The Quarterly Review of Biology · doi:10.1086/662453 · Cited by 61
Exoplasmic cysteine Cys384 of the HDL receptor SR-BI is critical for its sensitivity to a small-molecule inhibitor and normal lipid transport activity
Yu, M., Romer, K. A., Nieland, T. J. F., Xu, S., Saenz-Vash, V., Penman, M., Yesilaltay, A., Carr, S. A., & Krieger, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109078108 · Cited by 58
The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype
Brunzell, J. D., Zambon, A., & Deeb, S. S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.09.008 · Cited by 61
Relationship between serum cholesterol and indices of erythrocytes and platelets in the US population
Fessler, M. B., Rose, K. M., Zhang, Y., Jaramillo, R., & Zeldin, D. C. (2013) · Journal of Lipid Research · doi:10.1194/jlr.p037614 · Cited by 57
High density lipoprotein as a source of cholesterol for adrenal steroidogenesis: a study in individuals with low plasma HDL-C
Bochem, A. E., Holleboom, A. G., Romijn, J. A., Hoekstra, M., Dallinga-Thie, G. M., Motazacker, M. M., Hovingh, G. K., Kuivenhoven, J. A., & Stroes, E. S. G. (2013) · Journal of Lipid Research · doi:10.1194/jlr.p033449 · Cited by 56
Self-citation
Human genetics of HDL: Insight into particle metabolism and function
Brunham, L. R., & Hayden, M. R. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.01.001 · Cited by 54
Quercetin induces the selective uptake of HDL-cholesterol via promoting SR-BI expression and the activation of the PPARγ/LXRα pathway
Ren, K., Jiang, T., & Zhao, G.-J. (2017) · Food & Function · doi:10.1039/c7fo01107e · Cited by 53
High-density lipoprotein subfractions: current views and clinical practice applications
Martin, S. S., Jones, S. R., & Toth, P. P. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.05.005 · Cited by 54
High-density lipoproteins (HDL): Novel function and therapeutic applications
Darabi, M., & Kontush, A. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159058 · Cited by 52
Hepatic Scavenger Receptor BI Protects Against Polymicrobial-induced Sepsis through Promoting LPS Clearance in Mice
Guo, L., Zheng, Z., Ai, J., Huang, B., & Li, X. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.537258 · Cited by 49
Functional Characterization of Newly-Discovered Mutations in Human SR-BI
Chadwick, A. C., & Sahoo, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045660 · Cited by 49
Cholesteryl Ester Transfer Protein Expression Partially Attenuates the Adverse Effects of SR-BI Receptor Deficiency on Cholesterol Metabolism and Atherosclerosis
Bouhassani, M. E., Gilibert, S., Moreau, M., Saint-Charles, F., Tréguier, M., Potì, F., Chapman, M. J., Goff, W. L., Lesnik, P., & Huby, T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.220483 · Cited by 54
Apolipoprotein A-II is a key regulatory factor of HDL metabolism as appears from studies with transgenic animals and clinical outcomes
Maïga, S. F., Kalopissis, A. D., & Chabert, M. (2013) · Biochimie · doi:10.1016/j.biochi.2013.08.027 · Cited by 53
Mendelian Disorders of High-Density Lipoprotein Metabolism
Oldoni, F., Sinke, R. J., & Kuivenhoven, J. A. (2014) · Circulation Research · doi:10.1161/circresaha.113.300634 · Cited by 49
Self-citation
A new role for the P2X7 receptor: a scavenger receptor for bacteria and apoptotic cells in the absence of serum and extracellular ATP
Wiley, J. S., & Gu, B. J. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9308-5 · Cited by 47
Autoimmune Addison's disease
Napier, C., & Pearce, S. H. S. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2012.09.010 · Cited by 45
The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance
Wijers, M., Zanoni, P., Liv, N., Vos, D. Y., Jäckstein, M. Y., Smit, M., Wilbrink, S., Wolters, J. C., van der Veen, Y. T., Huijkman, N., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126462 · Cited by 44
Self-citation
Mining the genome for lipid genes
Kuivenhoven, J. A., & Hegele, R. A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.028 · Cited by 45
Self-citation
Hypocholesterolemia, foam cell accumulation, but no atherosclerosis in mice lacking ABC-transporter A1 and scavenger receptor BI
Zhao, Y., Pennings, M., Vrins, C. L. J., Calpe‐Berdiel, L., Hoekstra, M., Kruijt, J. K., Ottenhoff, R., Hildebrand, R. B., van der Sluis, R. J., Jessup, W., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.07.096 · Cited by 43
Self-citation
Adrenal-Specific Scavenger Receptor BI Deficiency Induces Glucocorticoid Insufficiency and Lowers Plasma Very-Low-Density and Low-Density Lipoprotein Levels in Mice
Hoekstra, M., van der Sluis, R. J., Eck, M. V., & van Berkel, T. J. C. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300784 · Cited by 43
Self-citation
Regulation of Expression and Function of Scavenger Receptor Class B, Type I (SR-BI) by Na+/H+ Exchanger Regulatory Factors (NHERFs)
Hu, Z., Hu, J., Zhang, Z., Shen, W., Yun, C. C., Berlot, C. H., Kraemer, F. B., & Azhar, S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.437368 · Cited by 40
HDL—A molecule with a multi-faceted role in coronary artery disease
Arora, S., Patra, S. K., & Saini, R. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.10.021 · Cited by 43
Functionality of postprandial larger HDL2 particles is enhanced following CETP inhibition therapy
Bellanger, N., Julia, Z., Villard, E. F., Khoury, P. E., Duchêne, E., Chapman, M. J., Fournier, N., Goff, W. L., & Guérin, M. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.12.027 · Cited by 39
SCARB1 Gene Variants Are Associated With the Phenotype of Combined High High-Density Lipoprotein Cholesterol and High Lipoprotein (a)
Yang, X., Sethi, A. A., Yanek, L. R., Knapper, C., Nordestgaard, B. G., Tybjærg‐Hansen, A., Becker, D. M., Mathias, R. A., Remaley, A. T., & Becker, L. C. (2016) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.116.001402 · Cited by 39
Lysosome-Independent Intracellular Drug/Gene Codelivery by Lipoprotein-Derived Nanovector for Synergistic Apoptosis-Inducing Cancer-Targeted Therapy
Wang, W., Chen, K., Su, Y., Zhang, J., Li, M., & Zhou, J. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.7b01549 · Cited by 38
SR-B1’s Next Top Model: Structural Perspectives on the Functions of the HDL Receptor
Powers, H. R., & Sahoo, D. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01001-1 · Cited by 39
Cardiac and skeletal muscles show molecularly distinct responses to cancer cachexia
Shum, A. M. Y., Fung, D. C. Y., Corley, S., McGill, M. C., Bentley, N. L., Tan, T. C., Wilkins, M. R., & Polly, P. (2015) · Physiological Genomics · doi:10.1152/physiolgenomics.00128.2014 · Cited by 38
Adrenocortical Scavenger Receptor Class B Type I Deficiency Exacerbates Endotoxic Shock and Precipitates Sepsis-Induced Mortality in Mice
Gilibert, S., Galle-Treger, L., Moreau, M., Saint-Charles, F., Costa, S., Ballaire, R., Couvert, P., Carrié, A., Lesnik, P., & Huby, T. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303164 · Cited by 37
Implications of reverse cholesterol transport: Recent studies
Levinson, S. S., & Wagner, S. G. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.10.018 · Cited by 36
Cholesteryl ester transfer protein: An enigmatic pharmacology – Antagonists and agonists
Yamashita, S., Ruscica, M., Macchi, C., Corsini, A., Matsuzawa, Y., & Sirtori, C. R. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.09.035 · Cited by 37
Familial hypercholesterolaemia: cholesterol efflux and coronary disease
Versmissen, J., Vongpromek, R., Yahya, R., van der Net, J. B., der Zee, L. V. V., Blommesteijn, J., Wattimena, D. J. L., Rietveld, T., Pullinger, C. R., Christoffersen, C., et al. (2016) · European Journal of Clinical Investigation · doi:10.1111/eci.12643 · Cited by 37
Functional validation of new pathways in lipoprotein metabolism identified by human genetics
Bauer, R. C., Stylianou, I. M., & Rader, D. J. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32834469b3 · Cited by 36
New developments in selective cholesteryl ester uptake
Meyer, J. M., Graf, G. A., & van der Westhuyzen, D. R. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283638042 · Cited by 39
An In-Silico Model of Lipoprotein Metabolism and Kinetics for the Evaluation of Targets and Biomarkers in the Reverse Cholesterol Transport Pathway
Lu, J. J.-Q., Hübner, K., Nanjee, M. N., Brinton, E. A., & Mazer, N. A. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003509 · Cited by 37
Novel concepts in HDL pharmacology
Remaley, A. T., Norata, G. D., & Catapano, A. L. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu141 · Cited by 36
Aerobic exercise training enhances the in vivo cholesterol trafficking from macrophages to the liver independently of changes in the expression of genes involved in lipid flux in macrophages and aorta
Pinto, P. R., Rocco, D. D. F. M., Okuda, L. S., Machado‐Lima, A., Castilho, G., da Silva, K. S., Gomes, D. J., Pinto, R. D. S., Iborra, R. T., Ferreira, G. S., et al. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0093-3 · Cited by 35
Shotgun proteomic analysis reveals proteome alterations in HDL of patients with cholesteryl ester transfer protein deficiency
Okada, T., Ohama, T., Takafuji, K., Kanno, K., Matsuda, H., Sairyo, M., Zhu, Y., Saga, A., Kobayashi, T., Masuda, D., et al. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.01.002 · Cited by 33
Genomic Variants and Multilevel Regulation of ABCA1, ABCG1, and SCARB1 Expression in Atherogenesis
Rozhkova, A. V., Dmitrieva, V. G., Nosova, E. V., Dergunov, A. D., Limborska, S. A., & Dergunova, L. V. (2021) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd8120170 · Cited by 39
Developmental abnormalities in mouse embryos lacking the HDL receptor SR-BI
Santander, N. G., Contreras‐Duarte, S., Awad, M. F., Lizama, C. O., Passalacqua, I., Rigotti, A., & Busso, D. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds510 · Cited by 34

Authors: Vergeer, M., Korporaal, S. J. A., Franssen, R., Meurs, I., Out, R., Hovingh, G. K., Hoekstra, M., Sierts, J. A., Dallinga-Thie, G. M., Motazacker, M. M., Holleboom, A. G., Van Berkel, T. J. C., Kastelein, J. J. P., Van Eck, M., & Kuivenhoven, J. A.
Affiliations: Amsterdam UMC Location University of Amsterdam (NL)
Leiden University (NL)
ORCID: Vergeer, Menno
Korporaal, Suzanne J.A.
Out, Ruud
Hovingh, G. Kees
Hoekstra, Menno
Motazacker, Mohammad Mahdi
Holleboom, Adriaan G.
Kastelein, John J.P.
Kuivenhoven, Jan Albert
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2011-01-13
Volume: 364
Issue: 2
Pages: 136-145
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa0907687
OpenAlex: W2077942032
Cited by: 317
References: 40
Citations by year: 2026: 7 · 2025: 8 · 2024: 7 · 2023: 7 · 2022: 18 · 2021: 17 · 2020: 14 · 2019: 19 · 2018: 17 · 2017: 29 · 2016: 14 · 2015: 29 · 2014: 34 · 2013: 34 · 2012: 31
FWCI: 42.84
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
Pure Amsterdam UMC (submittedVersion)
University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords: scavenger receptor class B type I, HDL cholesterol, high HDL cholesterol, cholesterol absorption, HDL binding, macrophage cholesterol efflux, atherosclerosis, platelet function, adrenal steroidogenesis, familial hypercholesterolemia
MeSH terms: Adolescent, Adrenal Insufficiency, Adrenal Glands, Adult, Aged, Aged, 80 and over, Animals, Carotid Arteries, Cholesterol, DNA Mutational Analysis, Female, Heterozygote, Homeostasis, Humans, Hydrocortisone, Cholesterol, HDL, Macrophages, Male, Middle Aged, Pedigree, Triglycerides, Platelet Activation, Mice, Knockout, Mutation, Missense, Atherosclerosis, Scavenger Receptors, Class B, Mice, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Genetic Variant of the Scavenger Receptor BI in Humans

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks